CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP · Real-Time Price · USD
56.09
-0.17 (-0.30%)
At close: Aug 1, 2025, 4:00 PM
56.25
+0.16 (0.29%)
After-hours: Aug 1, 2025, 7:59 PM EDT

CRISPR Therapeutics AG Stock Forecast

Stock Price Forecast

The 15 analysts that cover CRISPR Therapeutics AG stock have a consensus rating of "Buy" and an average price target of $70.73, which forecasts a 26.10% increase in the stock price over the next year. The lowest target is $32 and the highest is $120.

Price Target: $70.73 (+26.10%)
Analyst Consensus: Buy
TargetLowAverageMedianHigh
Price$32$70.73$78$120
Change-42.95%+26.10%+39.06%+113.94%

Analyst Ratings

The average analyst rating for CRISPR Therapeutics AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

RatingFeb '25Mar '25Apr '25May '25Jun '25Jul '25
Strong Buy776666
Buy444333
Hold998676
Sell111111
Strong Sell000000
Total212119161716

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
B of A Securities
B of A Securities
Strong Buy
Maintains
$79$78
Strong BuyMaintains$79$78+39.06%Jul 22, 2025
Needham
Needham
Strong Buy
Reiterates
$81
Strong BuyReiterates$81+44.41%Jul 8, 2025
Clear Street
Clear Street
Hold
Downgrades
$45
HoldDowngrades$45-19.77%Jun 27, 2025
Piper Sandler
Piper Sandler
Buy
Reiterates
$105
BuyReiterates$105+87.20%Jun 27, 2025
JMP Securities
JMP Securities
Buy
Reiterates
$86
BuyReiterates$86+53.33%Jun 27, 2025
More Analyst Ratings

Financial Forecast

Revenue This Year
47.88M
from 37.31M
Increased by 28.31%
Revenue Next Year
176.21M
from 47.88M
Increased by 268.05%
EPS This Year
-5.53
from -4.34
EPS Next Year
-4.56
from -5.53
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
719.00K914.96M1.20M371.21M37.31M47.88M176.21M410.76M
Revenue Growth
-99.75%127,154.94%-99.87%30,885.48%-89.95%28.31%268.05%133.11%
EPS
-5.294.70-8.36-1.94-4.34-5.53-4.56-3.55
EPS Growth
--------
Forward PE
--------
No. Analysts
-----313017
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20252026202720282029
High150.2M1.6B2.4B
Avg47.9M176.2M410.8M
Lown/an/a37.2M

Revenue Growth

Revenue Growth20252026202720282029
High
302.4%
3,145.8%
1,250.7%
Avg
28.3%
268.0%
133.1%
Low--
-78.9%

EPS Forecast

EPS20252026202720282029
High-4.002.684.94
Avg-5.53-4.56-3.55
Low-6.58-6.68-7.60

EPS Growth

EPS Growth20252026202720282029
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.